Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 5:1–18. doi: 10.1017/S1049023X20001533

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© World Association for Disaster and Emergency Medicine 2021

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Proportions of Causative Agent Exposure According to the Age Groups Over the Period (March through May) of 2016-2020.

Abbreviation: CNS, Central Nervous System.

Anticholinesterase compounds exposure presented as follows: 2016 (12.0%), 2017 (30.2%), 2018 (31.3%), 2019 (21.7%), and 2020 (4.8%).

Alcohols and drugs of abuse exposure presented as follows: 2016 (15.9%), 2017 (26.8%), 2018 (34.1%), 2019 (9.8%), and 2020 (13.4%).

Analgesic antipyretic exposure presented as follows: 2016 (32.0%), 2017 (18.0%), 2018 (26.2%), 2019 (17.2%), and 2020 (6.6%).

Phosphide exposure presented as follows: 2016 (8.6%), 2017 (20.6%), 2018 (28.6%), 2019 (24.2%), and 2020 (18.0%).

Corrosives and hydrocarbons exposure presented as follows: 2016 (20.3%), 2017 (20.8%), 2018 (34%), 2019 (15.8%), and 2020 (9.1%).

CNS depressants exposure presented as follows: 2016 (15.1%), 2017 (26.4%), 2018 (29.6%), 2019 (17.1%), and 2020 (11.8%).

Antipsychotics exposure presented as follows: 2016 (8.3%), 2017 (25.6%), 2018 (22.0%), 2019 (22.7%), and 2020 (21.4%).

Antidepressants exposure presented as follows: 2016 (13.2%), 2017 (15.1%), 2018 (28.3%), 2019 (32.1%), and 2020 (11.3%).

Cardiovascular and xanthine derivatives exposure presented as follows: 2016 (24.7%), 2017 (21.5%), 2018 (20.4%), 2019 (21.0%), and 2020 (12.4%).

Other non-classified toxic exposure presented as follows: 2016 (21.6%), 2017 (24.3%), 2018 (26.7%), 2019 (16.6%), and 2020 (10.8%).